American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
Chouinard, G., Ross-Chouinard, A., Annable, L., et al (1980) Extrapyramidal Symptom Rating Scale (abstract). Canadian Journal of Neurological Sciences, 7, 233.
Endicott, J., Spitzer, R. L., Fleiss, J. C., et al (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–771.
Ghaemi, S. N., Sachs, G. S., Baldassano, C. F., et al (1997) Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Canadian Journal of Psychiatry, 42, 196–199.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM). Rockville, MD: National Institute of Mental Health.
Kay, S. R., Fiszbein, A. & Opler, L. A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–275.
Marder, S. R., Davis, J. M. & Chouinard, G. (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry, 58, 538–546.
Miller, D. S., Yatham, L. N. & Lam, R. W. (2001) Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Journal of Clinical Psychiatry, 62, 975–980.
Montgomery, S. A. & Asberg, M. (1979) Anew depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Sachs, G. S., Grossman, F., Ghaemi, N. S., et al (2002) Risperidone plus mood stabilizer versus placebo plus mood stabilizer for acute mania of bipolar disorder: a double-blind comparison of efficacy and safety. American Journal of Psychiatry, 159, 1146–1154.
Sachs, G. S., Chengappa, K. N., Suppes, T., et al (2004) Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disorders, 6, 213–223.
Segal, J., Berk, M. & Brook, S. (1998) Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology, 21, 176–180.
Suppes, T., Webb, A., Paul, B., et al (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-refractory illness and a history of mania. American Journal of Psychiatry, 156, 1164–1169.
Tohen, M., Sanger, T. M., McElroy, S. L., et al (1999) Olanzapine versus placebo in the treatment of acute mania. American Journal of Psychiatry, 156, 702–709.
Tohen, M., Jacobs, T. G., Grundy, S. L., et al (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Archives of General Psychiatry, 57, 841–849.
Tohen, M., Chengappa, K. N. R., Suppes, T., et al (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium therapy. Archives of General Psychiatry, 59, 62–69.
Vieta, E., Goikolea, J. M., Corbella, B., et al (2001) Risperidone safety and efficacyin the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Journal of Clinical Psychiatry, 62, 818–825.
Vieta, E., Brugue, E., Goikolea, J. M., et al (2004) Acute and continuation risperidone monotherapyin mania. Human Psychopharmacology: Clinical and Experimental, 19, 41–45.
World Medical Association (1989) World Medical Association Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects. http://wwwfda.gov/oc/health/hesinki89.htm.
Yatham, L. N., Grossman, F., Augustyns, I., et al (2003) Mood stabilisers plus risperidone or placebo in the treatment of acute mania: international, double-blind, randomised controlled trial. British Journal of Psychiatry, 182, 141–147.
Young, R. C., Biggs, J. T., Ziegler, V. E., et al (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429–435.